IDXX Rule 144 Notice: Insider Sale of 7,143 Shares Valued $4.50M
Rhea-AI Filing Summary
Form 144 summary for IDEXX Laboratories, Inc. (IDXX)
This Form 144 reports a proposed sale of 7,143 shares of Common stock through Morgan Stanley Smith Barney LLC on NASDAQ with an aggregate market value of $4,503,160.87. Shares outstanding are listed as 80,004,694. The approximate date of sale is 08/06/2025.
The securities were acquired by stock option exercise on 08/06/2025 from the issuer and payment is listed as cash. The filing states "Nothing to Report" for securities sold during the past three months. Several filer and issuer contact fields (CIK, submission contact name/phone/email, date of notice, signature) are not provided in the extract.
Positive
- Proposed sale quantity disclosed: 7,143 shares listed for sale under Rule 144
- Aggregate market value provided: $4,503,160.87
- Acquisition details provided: Stock option exercise on 08/06/2025 with cash payment
- No recent disposals: "Nothing to Report" for securities sold during the past three months
Negative
- Filer identification fields missing in this extract: CIK and submission contact information not provided
- Administrative fields blank: Date of Notice and signature details are not populated in the provided content
Insights
TL;DR: Routine option exercise and Rule 144 sale of 7,143 shares; limited market or valuation impact given size and disclosed details.
The filing documents a standard Rule 144 notice for the proposed sale of 7,143 common shares valued at $4,503,160.87, transacted through Morgan Stanley Smith Barney LLC on 08/06/2025. The shares were acquired via a stock option exercise on the same date and paid in cash. The filing notes "Nothing to Report" for sales in the prior three months. For investors this appears to be a routine insider liquidity event rather than a material operational disclosure.
TL;DR: Disclosure follows Rule 144 format but the extract omits several identifying fields and the notice date/signature in this copy.
The form specifies the class, broker, number of shares, aggregate market value, acquisition method (stock option exercise) and payment method (cash). However, key administrative fields in the provided extract—such as filer CIK and submission contact details and the Date of Notice/signature block—are not populated here. The omission limits independent verification and timing clarity from this excerpt but does not contradict the core transaction details disclosed.